ABSTRACT. The effects of the cyclooxygenase inhibitor, indomethacin, and the leukotriene receptor antagonist, FPL 57231, on changes in dynamic lung compliance and pulmonary resistance associated with a 1-h infusion of live group B streptococci were evaluated in mechanically ventilated piglets. To define mediators of early changes in lung function, animals were given an infusion of either FPL 57231 or indomethacin beginning 15 min after the infusion of group B streptococci was begun. These groups were compared to an untreated group who received only group B streptococci. Within 15 min of starting the bacterial infusion, all groups showed significant increases in pulmonary artery pressure, pulmonary artery wedge pressure, total pulmonary resistance, transpulmonary pressure, and thromboxane B2, and decreases in tidal volume, dynamic lung compliance, and Pa02. After treatment with indomethacin there were significant decreases in pulmonary artery pressure (mean f SEM, 48 f 1 to 22 f 3 mm Hg, p < 0.001), pulmonary artery wedge pressure (7.5 f 1.3 to 2.2 f 0.4 mm Hg, p < 0.001) and thromboxane B2 (6.51 f 1.56 to 1.01 f 0.27 ng/ml, p < 0.01) and an increase in dynamic lung compliance (1.10 f 0.10 to 1.28 f 0.14 ml/ cm H20/kg, p < 0.01) over the study period. Total pulmonary resistance decreased significantly (18.7 f 1.8 to 15.7 2 1.5 cm H20/liter/s, p < 0.02) only at 60 min. In animals treated with FPL 57231 only pulmonary artery pressure (46 2 3 to 30 f 2 mm Hg, p < 0.05) and pulmonary artery wedge pressure (7.5 f 0.8 to 4.0 f 0.9 mm Hg, p < 0.01) decreased. These data suggest that cyclooxygenase products of arachidonic acid metabolism play a role in the early changes in pulmonary mechanics in group B streptococci sepsis. (Pediatr Res 22: 478-482, 1987) Abbreviations Cdyn, dynamic lung compliance GBS, group B streptococci Ppa, pulmonary artery pressure Ppaw, pulmonary artery wedge pressure Psa, systemic arterial pressure R , total pulmonary resistance
4Tx, thromboxane IV, intravenous Experimentally induced group B streptococcal infection using live organisms or exotoxin, and infusions of Escherichia coli endotoxin result in dramatic alterations in cardiovascular function characterized by elevations in pulmonary artery pressure and pulmonary vascular resistance and decreases in cardiac output and oxygenation (1-9). These early hemodynamic manifestations of gram-positive and gram-negative infections appear to be mediated by products of the cyclooxygenase pathway, especially TxA2 and prostacyclin (2,(4)(5)(6)(8)(9)(10)(11). However, recent investigation (1 2) has shown that a leukotriene receptor antagonist, FPL 57231, ameliorates the early hemodynamic changes associated with an infusion of live GBS in piglets, suggesting a role for leukotriene C4 and D4. The possible effects of lipoxygenase products of arachidonic acid metabolism on GBS-induced changes in lung function in a young animal model have not been defined.Alterations in pulmonary mechanics, which include decreased lung compliance and increased pulmonary res...